Harnessing Gene Correction for Endemic Disease: A Review of CRISPR-Cas9 Potential in Treating Genetic Diseases in Africa
Genetics & Applications · 02.04.2026 · 10 (1)
DOI: 10.31383/ga.vol10iss1ga03 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genetics & Applications, online erschienen am 02.04.2026. Verfasst von Kehinde Sowunmi und 1 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).
Abstract (Originalsprache)
Clustered regularly interspaced short palindromic repeats (CRISPR) alongside Cas9 has been a promising innovative genomic editing technology with potential to treat genetic diseases. It offers scientists the chance to edit DNA structures and change gene function. This review synthesises pre-clinical and early-phase data on its application against Africa’s highest-burden inherited disorders sickle-cell disease, β-thalassaemia, glucose-6-phosphate dehydrogenase (G6PD) deficiency and ornithine transcarbamylase (OTC) deficiency, cystic fibrosis, Duchenne muscular dystrophy and HIV-1 infection many of which are endemic and carry African-specific mutations. Using a structure review approach, we analysed > 80 peer-reviewed studies published 2015-2025 that employed African donor cells or relevant animal models. Key findings include ≥ 70 % on-target correction of prevalent variants (G6PD A− variant, CFTR A559T, BCL11A enhancer), functional rescue of enzyme activity or viral resistance, and absence of high-level off-target events when high-fidelity nucleases are used. The convergence of falling reagent costs, continent-specific mutation atlases and newly commissioned GMP facilities provides a realistic pathway for First-in-Human trials within 5–7 years. Implications include the potential to leapfrog from lifelong palliative care to one-shot cures, provided that Africa builds scientific infrastructure, trains local genome engineers and enacts harmonised regulatory frameworks that are both stringent and context-sensitive.
Zitieren
APA
Sowunmi, K., & Ogundele, O. (2026). Harnessing Gene Correction for Endemic Disease: A Review of CRISPR-Cas9 Potential in Treating Genetic Diseases in Africa. Genetics & Applications, 10(1). https://doi.org/10.31383/ga.vol10iss1ga03
Vancouver
Sowunmi K, Ogundele O. Harnessing Gene Correction for Endemic Disease: A Review of CRISPR-Cas9 Potential in Treating Genetic Diseases in Africa. Genetics & Applications. 2026;10(1). doi:10.31383/ga.vol10iss1ga03
BibTeX
@article{Sowunmi2026,
author = {Sowunmi, Kehinde and Ogundele, Olusegun},
title = {Harnessing Gene Correction for Endemic Disease: A Review of CRISPR-Cas9 Potential in Treating Genetic Diseases in Africa},
journal = {Genetics & Applications},
year = {2026},
volume = {10},
number = {1},
doi = {10.31383/ga.vol10iss1ga03}
}
EUVIMED